OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations
Franciele Cordeiro Gabriel, Daniela Oliveira de Melo, Renério Fráguas, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0231700-e0231700
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)
Magdalena Zielińska, Edyta Łuszczki, Katarzyna Dereń
Nutrients (2023) Vol. 15, Iss. 11, pp. 2433-2433
Open Access | Times Cited: 45

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
Jolanta Orzelska‐Górka, Joanna Mikulska, Anna Wiszniewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10624-10624
Open Access | Times Cited: 60

Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial
Annette Johansen, Sophia Armand, Pontus Plavén‐Sigray, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4272-4279
Open Access | Times Cited: 22

The Aversive Lens: Stress effects on the prefrontal-cingulate cortical pathways that regulate emotion
Amy F.T. Arnsten, Mary Kate P. Joyce, Angela Roberts
Neuroscience & Biobehavioral Reviews (2022) Vol. 145, pp. 105000-105000
Open Access | Times Cited: 30

Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Margarida Alberto, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2742-2742
Open Access | Times Cited: 30

Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Maja Jazvinšćak Jembrek, Nada Oršolić, Dalibor Karlović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6888-6888
Open Access | Times Cited: 19

The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
Claudia Savia Guerrera, Giuseppe Alessio Platania, Francesco Maria Boccaccio, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality
Franciele Cordeiro Gabriel, Aírton Tetelbom Stein, Daniela Oliveira de Melo, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281501-e0281501
Open Access | Times Cited: 17

Comparative effects of music interventions on depression in older adults: A systematic review and network meta-analysis
Teerapon Dhippayom, Thitinan Saensook, Natthamon Promkhatja, et al.
EClinicalMedicine (2022) Vol. 50, pp. 101509-101509
Open Access | Times Cited: 23

Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review
H. Lee, Vivian W. L. Tsang, Brandon Chai, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 3, pp. 301-315
Closed Access | Times Cited: 13

Management and treatment of ankle sprain according to clinical practice guidelines: A PRISMA systematic review
Francisco Javier Ruiz‐Sánchez, María Ruiz‐Muñoz, Jaime Martín‐Martín, et al.
Medicine (2022) Vol. 101, Iss. 42, pp. e31087-e31087
Open Access | Times Cited: 20

Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2825-2825
Open Access | Times Cited: 19

Should rTMS Be Considered a First-Line Treatment for Major Depressive Episodes in Adults?
Sean O’Sullivan, Derrick Matthew Buchanan, Jean-Marie Batail, et al.
Clinical Neurophysiology (2024) Vol. 165, pp. 76-87
Closed Access | Times Cited: 4

A systematic review of clinical practice guidelines for the assessment and management of pain in neonates
Natasha Campbell, Pauline Adair, Nicola Doherty, et al.
Journal of Neonatal Nursing (2025) Vol. 31, Iss. 2, pp. 101603-101603
Open Access

Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access

Violet light photobiomodulation therapy for depression: A double-blind randomized crossover trial
Yoshihiro Noda, Keita Taniguchi, Mayuko Takano, et al.
Journal of Affective Disorders (2025) Vol. 376, pp. 325-332
Closed Access

Unveiling the intricate connection between rumination, depression, and anxiety symptoms in Chinese college students: a network analysis
Yingxue Wang, Yuhao Wang, Blen Dereje Shiferaw, et al.
Current Psychology (2025)
Closed Access

Stereotactic Radiosurgery for Treatment Resistant Depression: Systematic Review
Jordan Vanleuven, Yusuke Hori, T. Osama, et al.
World Neurosurgery X (2025), pp. 100451-100451
Open Access

Simplified methods for SERT occupancy estimation measured with [11C]DASB PET bolus plus infusion
Magdalena Ponce de León, Matej Murgaš, Leo R. Silberbauer, et al.
NeuroImage (2025), pp. 121208-121208
Open Access

Defining Acute Kidney Injury
Siddharth Verma, John A. Kellum
Critical Care Clinics (2021) Vol. 37, Iss. 2, pp. 251-266
Closed Access | Times Cited: 25

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 4, pp. 715-727
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top